Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 827

1.

Long-term complications of chemotherapy for germ cell tumours.

Chaudhary UB, Haldas JR.

Drugs. 2003;63(15):1565-77. Review.

PMID:
12887263
2.

[Late toxicity after chemotherapy of malignant testicular tumors].

Jakob A, Kollmannsberger C, Kanz L, Bokemeyer C.

Urologe A. 1998 Nov;37(6):635-47. Review. German.

PMID:
9887493
3.

Late toxicity following curative treatment of testicular cancer.

Kollmannsberger C, Kuzcyk M, Mayer F, Hartmann JT, Kanz L, Bokemeyer C.

Semin Surg Oncol. 1999 Dec;17(4):275-81. Review.

PMID:
10588857
4.

Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.

Bokemeyer C.

Oncology. 1998 May-Jun;55(3):177-88. Review.

PMID:
9560052
5.

Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.

Berger CC, Bokemeyer C, Schneider M, Kuczyk MA, Schmoll HJ.

Eur J Cancer. 1995 Dec;31A(13-14):2229-38.

PMID:
8652248
6.

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.

Bokemeyer C, Köhrmann O, Tischler J, Weissbach L, Räth U, Haupt A, Schöffski P, Harstrick A, Schmoll HJ.

Ann Oncol. 1996 Dec;7(10):1015-21.

7.

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.

Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ.

Semin Oncol. 1998 Apr;25(2 Suppl 4):24-32; discussion 45-8. Review.

PMID:
9578059
8.

Diagnosis and treatment of patients with testicular germ cell cancer.

Hartmann JT, Kanz L, Bokemeyer C.

Drugs. 1999 Aug;58(2):257-81. Review.

PMID:
10473019
9.

Late complications of chemotherapy in testicular cancer.

Pliarchopoulou K, Pectasides D.

Cancer Treat Rev. 2010 May;36(3):262-7. doi: 10.1016/j.ctrv.2009.12.011. Epub 2010 Jan 25. Review.

PMID:
20092952
10.

Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer.

Hartmann JT, Kuczyk MA, Kollmannsberger C, Kanz L, Bokemeyer C.

World J Urol. 1999 Oct;17(5):324-33. Review.

PMID:
10552153
11.

Evaluation of long-term toxicity after chemotherapy for testicular cancer.

Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ.

J Clin Oncol. 1996 Nov;14(11):2923-32.

PMID:
8918489
12.

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.

Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP; Pediatric Oncology Group 9049; Children's Cancer Group 8882.

J Clin Oncol. 2004 Jul 1;22(13):2691-700.

13.

Vascular toxicity associated with chemotherapy for testicular cancer.

Gerl A.

Anticancer Drugs. 1994 Dec;5(6):607-14. Review.

PMID:
7534146
14.

The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors.

Bokemeyer C, Hartmann JT, Kuczyk MA, Truss MC, Beyer J, Jonas U, Kanz L.

World J Urol. 1996;14(6):354-9. Review.

PMID:
8986035
15.

Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.

Pont J, Albrecht W, Postner G, Sellner F, Angel K, Höltl W.

J Clin Oncol. 1996 Feb;14(2):441-8.

PMID:
8636755
16.

Treatment of testicular cancer and the development of secondary malignancies.

Bokemeyer C, Schmoll HJ.

J Clin Oncol. 1995 Jan;13(1):283-92. Review.

PMID:
7799032
17.
18.

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.

Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C; German Testicular Cancer Study Group.

J Clin Oncol. 2003 Nov 15;21(22):4083-91. Epub 2003 Oct 20.

PMID:
14568987
19.

Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.

Andrade RS, Kesler KA, Wilson JL, Brooks JA, Reichwage BD, Rieger KM, Einhorn LH, Brown JW.

Ann Thorac Surg. 2004 Oct;78(4):1224-8; discussion 1228-9. Review.

PMID:
15464475
20.

Early and long-term toxicity in the management of advanced germ cell testicular tumors.

Strohmeyer T, Geiser M, Ackermann R, Mumperow E, Hartmann M.

Eur Urol. 1988;15(3-4):205-8.

PMID:
2463922
Items per page

Supplemental Content

Write to the Help Desk